Radiomic: New Ai Research Tool Transforms 2026 Oncology Screening Efficiency Semanticscholar

Jan 14, 2026 • minute read

Contents

Artificial intelligence (ai) is reshaping population screening, yet the translation from laboratory performance to population benefit remains limited Here is the list of the top 22 startups applying ai in cancer research, diagnosis, and treatment to change and impact lives for the better. This narrative review describes current uses of ai across major screening pathways

SciSpace - Is This The Best AI Research & Data Analysis Tool in 2025? 🏆

Prospective trials in mammography demonstrate non‑inferior cancer … Download free practice tools, read journal articles, and more. This review highlights the transformative role of artificial intelligence (ai) in oncology, focusing on its applications in radiological imaging and radiogenomics

It demonstrates how ai integrates imaging and genomic data to enhance cancer diagnosis, treatment planning, and personalized medicine.

Despite advances in cancer diagnosis and treatment, the disease remains a major health challenge Abstract radiomics and artificial intelligence carry the promise of increased precision in oncologic imaging assessments due to the ability of harnessing thousands of occult digital imaging features embedded in conventional medical imaging data While powerful, these technologies suffer from a number of sources of variability that currently impede clinical translation In the last few years, new aspects of radiomics such as delta radiomics are being researched [69].

Lung cancer remains a leading cause of global cancer mortality, demanding improved early detection and personalized therapies This study introduces an innovative framework integrating deep learning (dl), radiomics, and explainable ai (xai) to significantly advance lung nodule analysis and predict actionable genetic mutations Moreover, the need for prospective validations and standardizations is emerging The integration of radiomics with artificial intelligence presents innovative avenues for cancer diagnosis, prognosis evaluation, and therapeutic choices

New Study Backs that Lunit's AI Model Transforms Chest Radiograph

Details

In the context of oncology, radiomics offers significant potential

Feature selection emerges as a pivotal step, enhancing the clinical utility and precision of radiomics. Lung cancer screening with ldct has been shown to reduce deaths from lung cancer by up to 24 percent, but as rates of lung cancer climb among nonsmokers, new strategies are needed to screen and accurately predict lung cancer risk across a wider population. Artificial intelligence (ai) in oncology is advancing beyond algorithm development to integration into clinical practice This review describes the current state of the field, with a specific focus on clinical integration.

The primary aim of the european oncology conference 2026 is to promote innovative research and advancements in cancer research, oncology, cancer therapy, and treatment, with a strong focus on ongoing and future perspectives The conference is expected to host over 100 delegates from various countries, fostering a truly international dialogue. More efficient and customized care is being made possible by recent developments in immunotherapy, targeted medicines, and the use of artificial intelligence in diagnosis and treatment planning.1 reviewing recent developments and current trends in cervical cancer research and treatment is the goal of this presentation. The results of the screening tool inform patient appointments with treating clinicians and inform the social support team (usually a social worker) of a patient's psychosocial and practical concerns

Nutriscore Screening Tool Identifies Risk for Malnutrition in Newly

Details

Discover how ai is transforming precision oncology and advancing personalized cancer treatment

Learn about ai's role in understanding complex biological systems, enhancing precision in immunotherapies, refining combination treatments, and optimizing clinical trials, with highlights on five innovative companies leading the way. See our takeaways here, and the full transcript below Radiomics holds untapped potential for pharma clinical trial biomarker strategy to improve tumor profiling, patient… Artificial intelligence is successfully being used to identify and treat cancer whilst building a knowledge database to help millions of people around the world.

(2015) [24] demonstrated that prognostic value of some radiomic features may be cancer type dependent The core of the preventive strategy is the assignment of an individual risk level of developing cancer Artificial intelligence (ai), which has emerged as a tool to reduce errors and confusion in data collection and analysis, has helped accelerate recent advances in identifying circulating markers to generate predictive methods. Attend 2026 oncology conferences to explore cancer research, treatment breakthroughs, and advances in cancer care.